Filing Details
- Accession Number:
- 0001237899-20-000016
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-04-13 19:23:31
- Reporting Period:
- 2020-04-09
- Accepted Time:
- 2020-04-13 19:23:31
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 872589 | Regeneron Pharmaceuticals Inc. | REGN | Pharmaceutical Preparations (2834) | 133444607 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1585160 | E Robert Landry | 777 Old Saw Mill River Road Tarrytown NY 10591 | Evp Finance Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-04-09 | 3,500 | $272.70 | 27,873 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-04-09 | 2,672 | $508.25 | 25,201 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2020-04-13 | 99 | $505.60 | 25,102 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-04-13 | 38 | $506.24 | 25,064 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-04-13 | 30 | $507.45 | 25,034 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-04-13 | 115 | $508.54 | 24,919 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-04-13 | 170 | $509.45 | 24,749 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-04-13 | 143 | $510.43 | 24,606 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-04-13 | 156 | $511.59 | 24,450 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-04-13 | 31 | $512.58 | 24,419 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-04-13 | 46 | $517.71 | 24,373 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2020-04-09 | 3,500 | $0.00 | 3,500 | $272.70 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 39,000 | 2023-09-09 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 172 | Indirect | By 401(k) Plan |
Footnotes
- Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
- Represents volume-weighted average price of sales of 30 shares of Company stock on April 13, 2020 at prices ranging from $507.44 to $507.84. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 13, 2020 at each separate price.
- Represents volume-weighted average price of sales of 115 shares of Company stock on April 13, 2020 at prices ranging from $508.24 to $508.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 13, 2020 at each separate price.
- Represents volume-weighted average price of sales of 170 shares of Company stock on April 13, 2020 at prices ranging from $509.03 to $509.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 13, 2020 at each separate price.
- Represents volume-weighted average price of sales of 143 shares of Company stock on April 13, 2020 at prices ranging from $510.11 to $510.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 13, 2020 at each separate price.
- Represents volume-weighted average price of sales of 156 shares of Company stock on April 13, 2020 at prices ranging from $511.23 to $511.73. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 13, 2020 at each separate price.
- Represents volume-weighted average price of sales of 31 shares of Company stock on April 13, 2020 at prices ranging from $512.01 to $512.62. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 13, 2020 at each separate price.
- The stock option award vests in four equal annual installments, commencing one year after the date of grant.
Billionaire Hedge Funds
